does semaglutide cause thirst Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Ozempic (semaglutide) is commonly used

MOTS-c influences mitochondrial signaling pathways that interact with the bodys fasted-state metabolic processes

A major insurance coverage wave dropped GLP-1 coverage for an estimated 24 million Americans

Protein powders not only may be high in sugar, artificial sweeteners, and additives but also risk being contaminated with harmful compounds

Data availability Individual participant data will be shared in data sets in a de-identified/anonymised format

The patients were randomized to different groups

Key findings from recent clinical trials The latest research shows multiple benefits that go far beyond weight loss: The FDA officially approved tirzepatide (Zepbound) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity making it the first FDA-approved medication specifically for OSA A systematic review showed GLP-1 receptor agonists significantly reduced the apnea-hypopnea index (AHI) in patients with type 2 diabetes (MD = -5.68, 95%CI [-7.97, -3.38]) Tirzepatide showed much better results than liraglutide in reducing AHI (MD = -21.89 vs